• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人淋巴因子激活的杀伤细胞及其前体的表面标志物。群体水平和克隆水平分析。

Surface markers of human lymphokine-activated killer cells and their precursors. Analysis at the population and clonal level.

作者信息

Ferrini S, Moretta L, Pantaleo G, Moretta A

出版信息

Int J Cancer. 1987 Jan 15;39(1):18-24. doi: 10.1002/ijc.2910390105.

DOI:10.1002/ijc.2910390105
PMID:3098689
Abstract

Lymphokine-activated killer (LAK) activity was first analyzed on PBL populations fractionated on the basis of the expression of T11 or T3 antigen. LAK cell precursors were found to be present in both T11+ and T11- populations, but only in the T3- cell fraction. The generation of LAK activity in highly purified T3- populations of PBL was not accompanied by expression of T3 antigen during a 5-day culture period. LAK activity was next analyzed at the level of limiting dilution clonal microcultures. T11+T3- and T11+T3+ cells, cloned under optimal culture conditions, gave a frequency of proliferating cells of approximately 1 cell in 1.25 for T11+T3+ and 1 cell in 10 for T11+T3- cells. Clones were screened for their ability to lyse fresh ovarian carcinoma cells and K562 target cells. The majority of LAK clones were derived from the T11+T3- cells; moreover, most of the clones derived from these cells displayed LAK activity. Clones displaying LAK activity lysed a panel of fresh or cultured tumor target cells, but failed to lyse PHA-activated lymphoblasts. Surface marker analysis indicated that all the clones had maintained the original T11/T3 phenotype. Whereas 2 T3+ selected LAK clones expressed the T8+T4- phenotype, only 1 out of 9 T3- clones was T8+T4-, all the others lacking both T4 and T8 antigens.

摘要

首先在根据T11或T3抗原表达进行分离的外周血淋巴细胞(PBL)群体上分析淋巴因子激活的杀伤细胞(LAK)活性。发现LAK细胞前体存在于T11 +和T11 -群体中,但仅存在于T3 -细胞组分中。在5天的培养期内,PBL的高度纯化的T3 -群体中LAK活性的产生并未伴随着T3抗原的表达。接下来在有限稀释克隆微培养水平上分析LAK活性。在最佳培养条件下克隆的T11 + T3 -和T11 + T3 +细胞,T11 + T3 +细胞的增殖细胞频率约为1.25个细胞中有1个,T11 + T3 -细胞为10个细胞中有1个。筛选克隆裂解新鲜卵巢癌细胞和K562靶细胞的能力。大多数LAK克隆源自T11 + T3 -细胞;此外,源自这些细胞的大多数克隆显示出LAK活性。显示LAK活性的克隆裂解一组新鲜或培养的肿瘤靶细胞,但不能裂解PHA激活的淋巴母细胞。表面标志物分析表明所有克隆都维持了原始T11 / T3表型。虽然2个T3 +选择的LAK克隆表达T8 + T4 -表型,但9个T3 -克隆中只有1个是T8 + T4 -,其他所有克隆都缺乏T4和T8抗原。

相似文献

1
Surface markers of human lymphokine-activated killer cells and their precursors. Analysis at the population and clonal level.人淋巴因子激活的杀伤细胞及其前体的表面标志物。群体水平和克隆水平分析。
Int J Cancer. 1987 Jan 15;39(1):18-24. doi: 10.1002/ijc.2910390105.
2
T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells.某些淋巴因子激活的杀伤细胞(LAK细胞)的T细胞性质。人T细胞群体中LAK前体细胞的频率分析及LAK效应细胞的克隆分析。
Eur J Immunol. 1986 Dec;16(12):1623-5. doi: 10.1002/eji.1830161224.
3
Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.重组白细胞介素2(rIL-2)诱导的活化杀伤细胞的表型和功能特征:群体水平和克隆水平分析
J Immunol. 1987 Feb 15;138(4):1297-302.
4
Glycoproteic nature of surface molecules of effector cells with lymphokine-activated killer (LAK) activity. Evidence that T11, T8 or T3 molecules are not involved in tumor-cell lysis by LAK effector T cells.具有淋巴因子激活的杀伤(LAK)活性的效应细胞表面分子的糖蛋白性质。关于T11、T8或T3分子不参与LAK效应T细胞对肿瘤细胞裂解的证据。
Int J Cancer. 1987 Jun 15;39(6):703-7. doi: 10.1002/ijc.2910390608.
5
Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.淋巴因子激活的杀伤(LAK)细胞现象。IV. LAK细胞克隆对来自自体和多种同种异体肿瘤的新鲜人肿瘤细胞的杀伤作用。
J Natl Cancer Inst. 1985 Jul;75(1):67-75.
6
Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.淋巴因子激活的杀伤细胞现象。II. 前体细胞表型在血清学上与外周T淋巴细胞、记忆性细胞毒性胸腺来源淋巴细胞及自然杀伤细胞不同。
J Exp Med. 1983 Mar 1;157(3):884-97. doi: 10.1084/jem.157.3.884.
7
A novel 120-kD surface antigen expressed by a subset of human lymphocytes. Evidence that lymphokine-activated killer cells express this molecule and use it in their effector function.一种由人类淋巴细胞亚群表达的新型120-kD表面抗原。有证据表明淋巴因子激活的杀伤细胞表达该分子并在其效应功能中使用它。
J Exp Med. 1987 Aug 1;166(2):319-26. doi: 10.1084/jem.166.2.319.
8
Phenotypic and functional analysis of human CD3+ and CD3- clones with "lymphokine-activated killer" (LAK) activity. Frequent occurrence of CD3+ LAK clones which produce interleukin-2.具有“淋巴因子激活的杀伤细胞”(LAK)活性的人CD3 +和CD3 -克隆的表型及功能分析。产生白细胞介素-2的CD3 + LAK克隆频繁出现。
Int J Cancer. 1987 Oct 15;40(4):495-8. doi: 10.1002/ijc.2910400411.
9
Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.白细胞介素2诱导人急性淋巴细胞白血病细胞表现出淋巴因子激活的杀伤细胞(LAK)细胞毒性。
J Immunol. 1987 Aug 1;139(3):977-82.
10
Lymphokine-activated killer cells. Analysis of progenitors and effectors.淋巴因子激活的杀伤细胞。祖细胞和效应细胞的分析。
J Exp Med. 1986 Oct 1;164(4):1193-205. doi: 10.1084/jem.164.4.1193.

引用本文的文献

1
Human cytolytic cell clones lacking surface expression of T cell receptor alpha/beta or gamma/delta. Evidence that surface structures other than CD3 or CD2 molecules are required for signal transduction.缺乏T细胞受体α/β或γ/δ表面表达的人细胞溶解细胞克隆。有证据表明信号转导需要CD3或CD2分子以外的表面结构。
J Exp Med. 1988 Jul 1;168(1):13-24. doi: 10.1084/jem.168.1.13.
2
Studies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker.淋巴因子激活的杀伤细胞(LAK细胞)的研究。I. 使用新型单克隆抗体的证据表明,大多数人LAK前体细胞共享一种共同的表面标志物。
J Exp Med. 1989 Mar 1;169(3):717-36. doi: 10.1084/jem.169.3.717.
3
Two populations of mouse lymphokine-activated killer cells separated by use of soybean agglutinin.
利用大豆凝集素分离出的两群小鼠淋巴因子激活的杀伤细胞。
Jpn J Cancer Res. 1989 Dec;80(12):1228-37. doi: 10.1111/j.1349-7006.1989.tb01659.x.
4
Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets.淋巴因子激活的杀伤(LAK)细胞克隆的表型和功能分析。CD3⁺ LAK细胞克隆在受到肿瘤靶标刺激时产生γ干扰素和肿瘤坏死因子的能力。
Cancer Immunol Immunother. 1989;29(4):270-8. doi: 10.1007/BF00199215.
5
Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studies.晚期恶性黑色素瘤中重组白细胞介素-2(rIL-2)联合黄酮醋酸(FAA)的免疫研究
Br J Cancer. 1990 Mar;61(3):471-4. doi: 10.1038/bjc.1990.104.
6
Mouse tumors are heterogeneous in their susceptibility to syngeneic lymphokine-activated killer cells and delineate functional subsets in such effectors.小鼠肿瘤对同基因淋巴因子激活的杀伤细胞的敏感性存在异质性,并在此类效应细胞中划分出功能亚群。
Cancer Immunol Immunother. 1990;31(1):37-43. doi: 10.1007/BF01742493.
7
Establishment of mouse lymphokine-activated killer cell clones and their properties.小鼠淋巴因子激活的杀伤细胞克隆的建立及其特性
Jpn J Cancer Res. 1991 Apr;82(4):456-63. doi: 10.1111/j.1349-7006.1991.tb01870.x.